Cardiac toxicity from antitumor therapy.
A review is made concerning cardiac toxicity from antitumor agents. The pattern, clinical course and fate of cardiac drug-related phenomena are considered. Special attention is drawn to new attempts to better understand, and possibly prevent, such a treatment limiting side-effect.
D000818:Animals; D000970:Antineoplastic Agents / Q000633:toxicity*; D004317:Doxorubicin / Q000633:toxicity; D006321:Heart / Q000187:drug effects*; D006801:Humans
D000970:Antineoplastic Agents; D004317:Doxorubicin